Literature DB >> 11396719

Differential storage of hydroxyethyl starch (HES) in the skin: an immunoelectron-microscopical long-term study.

S Ständer1, Z Szépfalusi, B Bohle, H Ständer, D Kraft, T A Luger, D Metze.   

Abstract

Hydroxyethyl starch (HES) is widely used as a plasma substitute. Serious side effects occur only rarely, whereas a high incidence of severe pruritus has been reported. Moreover, tissue storage of HES has been demonstrated in various organs. The aim of the current study has been to examine precisely the intracellular uptake and long-term storage of HES in the skin. Skin biopsies from 119 patients who received HES of various preparations and cumulative dosage were obtained 30 min to 130 months after infusion therapy. The samples were analysed by ultrastructural and immunoelectron microscopy with HES-specific monoclonal and polyclonal antibodies. A characteristic vacuolisation of perivascular histiocytes was a regular finding in all skin biopsies as early as 1 day after a single infusion of 30 g. Immunoreactivity for HES was demonstrable within the vacuoles. Generally, the size and number of vacuoles in the histiocytes increased concomitantly with the cumulative dosage. Following administration of higher HES dosages, vacuoles were demonstrable in endothelial cells of blood and lymphatic vessels, basal keratinocytes, epithelia of sweat glands and in small peripheral nerves, the last mentioned being associated with pruritus. A subsequent reduction of the vacuoles in size and number could be demonstrated within 52 months. In nerves, HES deposits persisted no longer than 17 months paralleling the cessation of pruritus. Biopsies taken after 94 months exhibited no HES deposits in the skin. The condensation and final dissolution of the vacuoles may either indicate the release and subsequent redistribution of HES into the circulation or lysosomal degradation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11396719     DOI: 10.1007/s004410000324

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  9 in total

Review 1.  Randomised trials of 6% tetrastarch (hydroxyethyl starch 130/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis.

Authors:  Amit Patel; Umeer Waheed; Stephen J Brett
Journal:  Intensive Care Med       Date:  2013-02-22       Impact factor: 17.440

Review 2.  Effect of molecular weight and substitution on tissue uptake of hydroxyethyl starch: a meta-analysis of clinical studies.

Authors:  Romuald Bellmann; Clemens Feistritzer; Christian J Wiedermann
Journal:  Clin Pharmacokinet       Date:  2012-04-01       Impact factor: 6.447

Review 3.  [Limited applications for hydroxyethyl starch : background and alternative concepts].

Authors:  M Rehm
Journal:  Anaesthesist       Date:  2013-08       Impact factor: 1.041

4.  [Hydroxyethyl starch-(HES)-induced pruritus as secondary complication of an occupational accident].

Authors:  E Weisshaar; S Ständer; D Metze; T L Diepgen
Journal:  Hautarzt       Date:  2004-06       Impact factor: 0.751

Review 5.  CONTRA: Hydroxyethyl starch solutions are unsafe in critically ill patients.

Authors:  Christiane Hartog; Konrad Reinhart
Journal:  Intensive Care Med       Date:  2009-06-17       Impact factor: 17.440

6.  Impairment of renal function using hyperoncotic colloids in a two hit model of shock: a prospective randomized study.

Authors:  Tim Philipp Simon; Tobias Schuerholz; Lars Hüter; Michael Sasse; Florian Heyder; Wolfgang Pfister; Gernot Marx
Journal:  Crit Care       Date:  2012-01-25       Impact factor: 9.097

7.  Hydroxyethyl starch (HES 130/0.4) impairs intestinal barrier integrity and metabolic function: findings from a mouse model of the isolated perfused small intestine.

Authors:  Yuk Lung Wong; Ingmar Lautenschläger; Heike Dombrowsky; Karina Zitta; Berthold Bein; Thorsten Krause; Torsten Goldmann; Inez Frerichs; Markus Steinfath; Norbert Weiler; Martin Albrecht
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

8.  Adverse effects of hydroxyethyl starch (HES 130/0.4) on intestinal barrier integrity and metabolic function are abrogated by supplementation with Albumin.

Authors:  Yuk Lung Wong; Ingmar Lautenschläger; Karina Zitta; Christin Schildhauer; Kerstin Parczany; Christoph Röcken; Markus Steinfath; Norbert Weiler; Martin Albrecht
Journal:  J Transl Med       Date:  2016-02-27       Impact factor: 5.531

Review 9.  Accumulation of hydroxyethyl starch in human and animal tissues: a systematic review.

Authors:  Christian J Wiedermann; Michael Joannidis
Journal:  Intensive Care Med       Date:  2013-11-21       Impact factor: 17.440

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.